China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

CBPO 76.60 -0.31 (-0.40%)
price chart
China Biologic Products CBPO) Falls: Stock Goes Down 6%
China Biologic Products, Inc. (CBPO - Snapshot Report) saw a big move last session, as the company's shares fell nearly 6% on the day.
China Biologic Products Earnings Preview (CBPO)
China Biologic Products (NASDAQ: CBPO), a biopharmaceutical company focused on developing plasma-based products, has been subjected to a roller coaster ride over the last several months. Back in mid June, shares fell more than 11% after the ...
Related articles »  
China Biologic Products Becomes Oversold (CBPO)
In trading on Monday, shares of China Biologic Products Inc (NASD: CBPO) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $49.11 per share.
Related articles »  
Stock in Focus : China Biologic Products, Inc. (NASDAQ:CBPO)
China Biologic Products, Inc. (NASDAQ:CBPO) (TREND ANALYSIS) shares were traded with more than 50% increase in usual volume.
Ups & Downs At Street: China Biologic Products, Inc. (NASDAQ:CBPO ...  eMarketsDaily
Update: China Biologic Products Adopts Stockholder Plan To Avoid Hostile ...
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Why China Biologic Products (CBPO) Could Be an Impressive Growth Stock
One such company that might be well-positioned for future earnings growth is China Biologic Products, Inc. (CBPO - Snapshot Report).
Related articles »  
China Biologic Products' (CBPO) CEO David Gao on Q3 2014 Results ...
Hello, everyone and thank you for joining us on today's call. China Biologic announced its quarterly financial results on November 5 after the market closed.
Related articles »  
China Biologic Products to Report Fourth Quarter and Fiscal Year 2014 ...
BEIJING, Feb. 17, 2015 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release ...
Mid-Day Changers: China Biologic Products, Inc. (CBPO), Semler Scientific ...  WallStreet Scope
Declarations in Focus: Discovery Laboratories Inc. (NASDAQ:DSCO), China ...  eMarketsDaily
China Biologic Presents A Unique Investment Opportunity
Undoubtedly, both China Biologic's majority stake in Guizhou and its two successive quarters of rising product revenues are healthy signs of a rapidly growing healthcare company. Nevertheless, with such impressive growth and incredible stock ...
China Biologic Receives GMP Certification for New Coagulation Factor Facility
BEIJING, Dec. 23, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, ...
Related articles »